
News|Articles|February 13, 2019
Firdapse for LEMS in Adults
Author(s)Drew Boxler
Advertisement
Firdapse (amifampridine, Catalyst Pharmaceuticals)
Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
Dosage: 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily); increased by 5mg daily every 3-4 days, not to exceed 80mg daily
Contraindications: History of seizures; hypersensitivity to amifampridine or another aminopyridine
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
2
American Pharmacists Month: Expanding Services Through Dedicated Pharmacy Clinic
3
Automation Helps Pharmacies Maximize Revenue, Improve Patient Care | NCPA 2025
4
American Pharmacists Month: Pharmacist Champions Preventative Medicine Approach to Care
5


























































































































































